FDA: Letter to the Industry on COVID-19
March 26, 2020
The FDA has written a letter addressed to medical device establishments in order to address the impact of the COVID-19 pandemic on day-to-day operations in the FDA’s Center for Devices and Radiological Health (CDRH) and in the medical device industry.
Recent News
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies